Inhibitor Therapeutics, Inc.
INTI· OTC
INTIInhibitor Therapeutics, Inc.
Quarterly figures for Inhibitor Therapeutics, Inc., with source filings when available.
56 quarters. Sep 30, 2012 to Jun 30, 2026. USD.
Inhibitor Therapeutics, Inc. has filed its 10-Q within 37 to 45 days of period end across its last 8 quarters. The 10-K runs 66 to 90 days.
Inhibitor Therapeutics, Inc. · CIK 1042418 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 14, 2026 | 45 d | 10-Q | — | — | $0.00 | |
| Q1 2026 | Mar 31, 2026 | — | May 15, 2026 | 45 d | 10-Q | — | — | $0.00 | |
| FY 2025 | |||||||||
| Q4 2025derived | Dec 31, 2025 | — | Mar 26, 2026 | 85 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 13, 2025 | 44 d | 10-Q | ||||
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | — | Mar 28, 2025 | 87 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 12, 2024 | 43 d | 10-Q | ||||
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Mar 29, 2024 | 89 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 13, 2023 | 44 d | 10-Q | ||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | — | Mar 31, 2023 | 90 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | ||||
| FY 2021 | |||||||||
| Q4 2021derived | Dec 31, 2021 | — | Mar 30, 2022 | 89 d | 10-K | $0.00 | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 12, 2021 | ||||||
| FY 2020 | |||||||||
| Q4 2020derived | Dec 31, 2020 | — | Mar 26, 2021 | 85 d | 10-K | $0.00 | — | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 16, 2020 | ||||||
| FY 2019 | |||||||||
| Q4 2019derived | Dec 31, 2019 | — | Mar 30, 2020 | 90 d | 10-K | $0.00 | — | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 7, 2019 | ||||||
| FY 2018 | |||||||||
| Q4 2018derived | Dec 31, 2018 | — | Mar 7, 2019 | 66 d | 10-K | — | — | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 14, 2018 | 45 d | 10-Q | ||||
| FY 2017 | |||||||||
| Q4 2017derived | Dec 31, 2017 | — | Feb 16, 2018 | 47 d | 10-K | $0.00 | — | — | |
| Q3 2017 | Sep 30, 2017 | — | Oct 31, 2017 | ||||||
| FY 2016 | |||||||||
| Q4 2016derived | Dec 31, 2016 | — | Feb 17, 2017 | 48 d | 10-K | $0.00 | — | — | |
| Q3 2016 | Sep 30, 2016 | — | Oct 31, 2016 | ||||||
| FY 2015 | |||||||||
| Q4 2015derived | Dec 31, 2015 | — | Feb 1, 2016 | 32 d | 10-K | $0.00 | — | — | |
| Q3 2015 | Sep 30, 2015 | — | Nov 4, 2015 | ||||||
| FY 2014 | |||||||||
| Q4 2014derived | Dec 31, 2014 | — | Feb 13, 2015 | 44 d | 10-K | $0.00 | — | — | |
| Q3 2014 | Sep 30, 2014 | — | Oct 10, 2014 | ||||||
| FY 2013 | |||||||||
| Q4 2013derived | Dec 31, 2013 | — | Apr 15, 2014 | 105 d | 10-K | — | — | — | |
| Q3 2013 | Sep 30, 2013 | — | Nov 14, 2013 | 45 d | 10-Q | ||||
| FY 2012 | |||||||||
| Q4 2012derived | Dec 31, 2012 | — | May 20, 2013 | 140 d | 10-K | — | — | — | |
| Q3 2012 | Sep 30, 2012 | — | Nov 19, 2012 | 50 d | 10-Q | ||||
| — |
| — |
| $0.00 |
| Q2 2025 | Jun 30, 2025 | — | Aug 13, 2025 | 44 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2025 | Mar 31, 2025 | — | May 14, 2025 | 44 d | 10-Q | — | — | $0.00 |
|---|
| — |
| — |
| $0.00 |
| Q2 2024 | Jun 30, 2024 | — | Aug 6, 2024 | 37 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2024 | Mar 31, 2024 | — | May 13, 2024 | 43 d | 10-Q | — | — | $0.00 |
|---|
| — |
| — |
| $0.00 |
| Q2 2023 | Jun 30, 2023 | — | Aug 11, 2023 | 42 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2023 | Mar 31, 2023 | — | May 15, 2023 | 45 d | 10-Q | — | — | $0.00 |
|---|
| $0.00 |
| — |
| $0.00 |
| Q2 2022 | Jun 30, 2022 | — | Aug 12, 2022 | 43 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2022 | Mar 31, 2022 | — | May 13, 2022 | 43 d | 10-Q | $0.00 | — | $0.00 |
|---|
| 43 d |
| 10-Q |
| $0.00 |
| — |
| $0.00 |
| Q2 2021 | Jun 30, 2021 | — | Aug 13, 2021 | 44 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2021 | Mar 31, 2021 | — | May 14, 2021 | 44 d | 10-Q | $0.00 | — | $0.00 |
|---|
| 47 d |
| 10-Q |
| $0.00 |
| — |
| $0.00 |
| Q2 2020 | Jun 30, 2020 | — | Aug 12, 2020 | 43 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2020 | Mar 31, 2020 | — | May 1, 2020 | 31 d | 10-Q | $0.00 | — | $0.00 |
|---|
| 38 d |
| 10-Q |
| $0.00 |
| — |
| $0.00 |
| Q2 2019 | Jun 30, 2019 | — | Aug 12, 2019 | 43 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2019 | Mar 31, 2019 | — | May 9, 2019 | 39 d | 10-Q | $0.00 | — | $0.00 |
|---|
| — |
| — |
| $0.00 |
| Q2 2018 | Jun 30, 2018 | — | Jul 23, 2018 | 23 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2018 | Mar 31, 2018 | — | May 1, 2018 | 31 d | 10-Q | — | — | $0.00 |
|---|
| 31 d |
| 10-Q |
| $0.00 |
| — |
| $0.00 |
| Q2 2017 | Jun 30, 2017 | — | Jul 31, 2017 | 31 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2017 | Mar 31, 2017 | — | May 8, 2017 | 38 d | 10-Q | $0.00 | — | -$0.01 |
|---|
| 31 d |
| 10-Q |
| $0.00 |
| — |
| -$0.01 |
| Q2 2016 | Jun 30, 2016 | — | Aug 12, 2016 | 43 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2016 | Mar 31, 2016 | — | May 13, 2016 | 43 d | 10-Q | $0.00 | — | $0.00 |
|---|
| 35 d |
| 10-Q |
| $0.00 |
| — |
| $0.00 |
| Q2 2015 | Jun 30, 2015 | — | Aug 14, 2015 | 45 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2015 | Mar 31, 2015 | — | May 13, 2015 | 43 d | 10-Q | $0.00 | — | $0.00 |
|---|
| 10 d |
| 10-Q |
| $0.00 |
| — |
| -$0.01 |
| Q2 2014 | Jun 30, 2014 | — | Aug 13, 2014 | 44 d | 10-Q | $0.00 | — | -$0.10 |
|---|
| Q1 2014 | Mar 31, 2014 | — | May 12, 2014 | 42 d | 10-Q | $0.00 | — | -$0.01 |
|---|
| — |
| — |
| -$0.07 |
| Q2 2013 | Jun 30, 2013 | — | Sep 6, 2013 | 68 d | 10-Q | $0.00 | — | -$0.01 |
|---|
| Q1 2013 | Mar 31, 2013 | — | May 20, 2013 | 50 d | 10-Q | — | — | — |
|---|
| — |
| — |
| $0.05 |
